Purple Biotech (PPBT) EV to EBITDA (2015 - 2026)
Purple Biotech (PPBT) EV to EBITDA (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to EBITDA |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-874.56 |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-566,202.17 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-197,878.48 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-58,863.88 |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-168,912.54 |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-304,774.20 |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
22.61 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
-304.27 |
| 10 |
Purple Biotech |
242.86 Mn |
236.43 Mn |
- |
9.05 |
| Date | Value |
|---|
| Jun 12, 2026 |
9.05 |
| Jun 11, 2026 |
8.93 |
| Jun 10, 2026 |
16.82 |
| Jun 9, 2026 |
17.20 |
| Jun 8, 2026 |
16.82 |
| Jun 5, 2026 |
17.23 |
| Jun 4, 2026 |
17.93 |
| Jun 3, 2026 |
17.11 |
| Jun 2, 2026 |
17.52 |
| Jun 1, 2026 |
0.00 |
| May 29, 2026 |
0.00 |
| May 28, 2026 |
0.00 |
| May 27, 2026 |
0.00 |
| May 26, 2026 |
0.00 |
| May 22, 2026 |
0.00 |
| May 21, 2026 |
93.38 |
| May 20, 2026 |
110.39 |
| May 19, 2026 |
121.15 |
| May 18, 2026 |
130.87 |
| May 15, 2026 |
136.43 |
